Prashant Tembhare

Distinguishing hairy cell leukemia variant from hairy cell leukemia: Development and validation of diagnostic criteria

Haipeng Shao, Katherine R. Calvo, Marlene Grönborg et al. · Leukemia Research · 2013 · 123 citations · Full text

Hematological Malignancy, Mixed-phenotype Acute Leukemia, Pathology +4

Modeling progression risk for smoldering multiple myeloma: results from a prospective clinical study

Benjamin M. Cherry, Neha Korde, Mary Kwok et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2013 · 99 citations · Full text

Hematological Malignancy, Epidemiology, Oncology +15

Flow cytometric differentiation of abnormal and normal plasma cells in the bone marrow in patients with multiple myeloma and its precursor diseases

Prashant Tembhare, Constance M. Yuan, David Venzon et al. · Leukemia Research · 2013 · 95 citations

Hematological Malignancy, Bone Marrow Failure, Health Sciences +13

Clinical impact of panel-based error-corrected next generation sequencing versus flow cytometry to detect measurable residual disease (MRD) in acute myeloid leukemia (AML)

Nikhil Patkar, Chinmayee Kakirde, Anam Fatima Shaikh et al. · Leukemia · 2021 · 92 citations · Full text

A High‐Sensitivity 10‐Color Flow Cytometric Minimal Residual Disease Assay in B‐Lymphoblastic Leukemia/Lymphoma Can Easily Achieve the Sensitivity of 2‐in‐10⁶and Is Superior to Standard Minimal Residual Disease Assay: A Study of 622 Patients

Prashant Tembhare, Papagudi Ganesan Subramanian, Sitaram Ghogale et al. · Cytometry Part B Clinical Cytometry · 2019 · 74 citations · Full text